Reply to: Which is the best timing of bile duct division in living liver donor surgery?
Silvio Nadalin, Giuliano Testa – 30 July 2007
Silvio Nadalin, Giuliano Testa – 30 July 2007
Gerd Otto – 30 July 2007
Didier Samuel, Anne Marie Roque‐Afonso – 30 July 2007
Mitchell L. Shiffman – 30 July 2007
Prabhleen Chahal, Todd H. Baron, John J. Poterucha, Charles B. Rosen – 30 July 2007 – Endoscopic retrograde cholangiography (ERC) is a well‐established modality for diagnostic and therapeutic maneuvers in pancreaticobiliary disorders. However, it is technically more challenging in patients with postsurgical anatomy like Roux‐en‐Y anastomoses. Its effectiveness in post–orthotopic liver transplantation (OLT) patients with Roux‐en‐Y biliary reconstruction has not been reported. We sought to assess the efficacy and safety of ERC in this patient population.
Angelo Luca, Berhard Angermayr, Guido Bertolini, Franz Koenig, Giovanni Vizzini, Martin Ploner, Markus Peck‐Radosavljevic, Bruno Gridelli, Jaime Bosch – 30 July 2007 – The Model for End‐Stage Liver Disease (MELD) is widely used to predict the short‐term mortality in patients with cirrhosis, but potential limitations of this score have been reported. The aim of this study was to improve the score's prognostic accuracy by assessing new objective variables.
James D. Perkins – 30 July 2007
Muhammad F. Dawwas, James D. Lewsey, James M. Neuberger, Alexander E. Gimson – 30 July 2007 – Modification of the current allocation system for donor livers in the United States to incorporate recipient serum sodium concentration ([Na]) has recently been proposed. However, the impact of this parameter on posttransplantation mortality has not been previously examined in a large risk‐adjusted analysis.
Li Feng, Na Zhao, Xun Yao, Xin Sun, Liang Du, Xiang Diao, Shengfu Li, Youping Li – 30 July 2007 – University of Wisconsin (UW) solution has been recognized as the gold standard in liver preservation, but its limitations are becoming obvious, such as risk of biliary complications and its high cost. Alternatively, the effects of histidine‐tryptophan‐ketoglutarate (HTK), such as improved biliary protection and low cost, have been observed. This systematic review is conducted to compare the efficacy and safety of these 2 solutions. Databases from 1966 to June 2006 were searched.